Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Total Liabilities: 2023-2024

Historic Total Liabilities for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $15.2 million.

  • Compass Therapeutics' Total Liabilities rose 101.30% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 101.30%. This contributed to the annual value of $15.2 million for FY2024, which is 81.96% up from last year.
  • Per Compass Therapeutics' latest filing, its Total Liabilities stood at $15.2 million for FY2024, which was up 81.96% from $8.3 million recorded in FY2023.
  • Over the past 5 years, Compass Therapeutics' Total Liabilities peaked at $15.2 million during FY2024, and registered a low of $8.3 million during FY2023.
  • For the 2-year period, Compass Therapeutics' Total Liabilities averaged around $11.8 million, with its median value being $11.8 million (2023).
  • Data for Compass Therapeutics' Total Liabilities shows a peak YoY skyrocketed of 81.96% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Compass Therapeutics' Total Liabilities stood at $8.3 million in 2023, then surged by 81.96% to $15.2 million in 2024.